Heritage Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.6K Sell
436
-1,120
-72% -$172K ﹤0.01% 290
2025
Q4
$215K Hold
1,556
0.01% 213
2025
Q3
$200K Hold
1,556
0.01% 201
2025
Q2
$188K Buy
1,556
+51
+3% +$5.75K 0.01% 211
2025
Q1
$168K Hold
1,505
0.01% 211
2024
Q4
$146K Hold
1,505
0.01% 227
2024
Q3
$173K Hold
1,505
0.01% 226
2024
Q2
$160K Hold
1,505
0.01% 220
2024
Q1
$146K Hold
1,505
0.01% 235
2023
Q4
$152K Hold
1,505
0.01% 234
2023
Q3
$153K Sell
1,505
-180
-11% -$18.3K 0.01% 218
2023
Q2
$170K Hold
1,685
0.01% 215
2023
Q1
$155K Sell
1,685
-180
-10% -$15.7K 0.01% 223
2022
Q4
$169K Hold
1,865
0.01% 226
2022
Q3
$142K Hold
1,865
0.01% 230
2022
Q2
$158K Buy
1,865
+565
+43% +$49.6K 0.01% 222
2022
Q1
$114K Hold
1,300
0.01% 241
2021
Q4
$114K Sell
1,300
-150
-10% -$12.5K 0.01% 254
2021
Q3
$119K Hold
1,450
0.01% 236
2021
Q2
$132K Hold
1,450
0.01% 229
2021
Q1
$124K Sell
1,450
-141
-9% -$12.7K 0.01% 242
2020
Q4
$150K Hold
1,591
0.01% 221
2020
Q3
$138K Hold
1,591
0.02% 178
2020
Q2
$139K Hold
1,591
0.02% 171
2020
Q1
$131K Hold
1,591
0.02% 159
2019
Q4
$151K Buy
1,591
+141
+10% +$12.7K 0.02% 194
2019
Q3
$126K Buy
1,450
+227
+19% +$20.4K 0.02% 194
2019
Q2
$112K Buy
1,223
+367
+43% +$31.1K 0.02% 184
2019
Q1
$73.7K Hold
856
0.01% 200
2018
Q4
$65K Sell
856
-56
-6% -$4.36K 0.01% 179
2018
Q3
$70K Buy
+912
New +$67.4K 0.01% 173

Other funds holding NVS

Heritage Wealth Advisors's NVS Position: Q1 2026 in Review

Heritage Wealth Advisors reduced its Novartis (NVS) stake by 72% in Q1 2026, selling an estimated $172K and leaving 436 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Heritage Wealth Advisors first reported a position in NVS in Q3 2018 and has held it in 31 quarters since. The position peaked at $215K in Q4 2025. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Heritage Wealth Advisors held 436 shares of Novartis worth $66.6K as of Q1 2026.
  • Heritage Wealth Advisors sold 1,120 Novartis shares in Q1 2026, an estimated $172K.
  • Novartis made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #290 holding.
  • Heritage Wealth Advisors first reported a position in Novartis in Q3 2018 and has held it in 31 quarters since.
  • Heritage Wealth Advisors's Novartis position peaked at $215K in Q4 2025.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.